<s>[INST] The next text is a question of a member of the European parliament:"The Commission has ordered vaccines against the SARS-CoV-2 coronavirus from a number of laboratories subsequent to a commitment, in the case of each order, of at least three Member States to use them. The additional or supernumerary doses will be split according to an EU distribution strategy.Unfortunately the Commission is keeping the contracts signed with laboratories under wraps, despite numerous repeated requests from MEPs – myself included – and Parliamentary committees.However, and in order to respect the minimum level of transparency required in its vaccine strategy, which is not confidential, will the Commission:1.Provide a precise, up-to-date breakdown of the vaccines by manufacturer and by Member State?2.State the unit and wholesale cost of these vaccines, which has already been partly revealed by the press and a post from Belgium’s State Secretary for the Budget?3.Specify the logistical phases of the entire vaccination campaign, as well as their schedule?At a time when the public are more sceptical of the vaccine than ever, they need reassurance, and Europeans must have a good exit strategy."
Analyze carefully the text and assign it to the most relevant policy area among those listed below. Do not explain your answer and return only a number.
Policy area numbers: 1 = Macroeconomics
2 = Civil Rights, Minority Issues and Civil Liberties
3 = Health
4 = Agriculture and Fisheries
5 = Labour, employment and pensions
6 = Education
7 = Environment
8 = Energy
9 = Immigration
10 = Transportation
12 = Law and Crime
13 = Social welfare
14 = Regional and Urban issues and Planning
15 = Banking, finance and domestic commerce issues
16 = Defence
17 = Space, science, technology, and communications issues
18 = Foreign trade
19 = International affairs and foreign aid
20 = Governance and government
21 = Public Lands, Water Management and Territorial Issues
23 = Culture and media
[/INST]. Answer = [3]. </s>
The Commission has ordered vaccines against the SARS-CoV-2 coronavirus from a number of laboratories subsequent to a commitment, in the case of each order, of at least three Member States to use them. The additional or supernumerary doses will be split according to an EU distribution strategy.Unfortunately the Commission is keeping the contracts signed with laboratories under wraps, despite numerous repeated requests from MEPs – myself included – and Parliamentary committees.However, and in order to respect the minimum level of transparency required in its vaccine strategy, which is not confidential, will the Commission:1.Provide a precise, up-to-date breakdown of the vaccines by manufacturer and by Member State?2.State the unit and wholesale cost of these vaccines, which has already been partly revealed by the press and a post from Belgium’s State Secretary for the Budget?3.Specify the logistical phases of the entire vaccination campaign, as well as their schedule?At a time when the public are more sceptical of the vaccine than ever, they need reassurance, and Europeans must have a good exit strategy.